The World Health Organization (WHO) has given the green light on Friday for the use of preventive medicine in patients infected with Covid-19.
The medicine can only be used if patients have not produced sufficient antibodies themselves, for example, because they are taking immunosuppressive medication.
It concerns a combination of casirivimab and imdevimab from the American pharmaceutical company Regeneron and Swiss manufacturer Roche, which ensures that the coronavirus is less able to penetrate the human cell. At the Erasmus MC in Rotterdam, patients are already being treated with a combination of drugs.
The method is not cheap, and the WHO is calling on countries to push manufacturers to lower prices, the organization writes in a statement. It is the third treatment method for Covid-19 patients to be approved by the WHO.